Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Interstitial Colloidal 32P Integrated in The Treatment of Non-Resectable Pancreatic Cancer

NCT00002689 is registered in ClinicalTrials.gov with Center for Molecular Medicine as lead sponsor.

NCT NCT00002689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Interstitial Colloidal 32P Integrated in The Treatment of Non-Resectable Pancreatic Cancer
Lead sponsor
Center for Molecular Medicine
Phase
Phase 2
Overall status
Completed
Start date
September 30, 1995
Completion date
June 30, 2007
Enrollment
48 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer